Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models

✍ Scribed by Yesim Gökmen-Polar, Yi Liu, Rachel A. Toroni, Kerry L. Sanders, Rutika Mehta, Sunil Badve, Christian Rommel, George W. Sledge Jr.

• Book ID: 118796786
• Publisher: Springer US
• Year: 2012
• Tongue: English
• Weight: 525 KB
• Volume: 136
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-012-2298-8